TABLE 5.
Herb name in Pin yin a | Plant names b | Preparation | Chemical composition | Subject | Pharmacological effects | Mechanisms of action | References |
---|---|---|---|---|---|---|---|
Ren shen | Panax ginseng C.A.Mey | Compound | Ginsenoside Rg1 | AD mice (transgenic mice, aged mice, ovariectomy plus intracranial injections of D-galactose, hippocampus injury, chronic stress, ovariectomy, injection of okamoto acid, quinolinic acid, the Aβ1-42 and Aβ25-35, dexamethasone, D-galactose, scopolamine) | Antioxidant | SOD ↑, GSH-PX ↑ | Liang et al. (2021) |
ROS ↓, MDA ↓ | |||||||
Anti-inflammatory | TNF-α ↓, IL-1β ↓, IL-6 ↓, IL-18 ↓, caspase 1 ↓, caspase 5 ↓ | ||||||
Upregulation of nerve cells | NSC senescence ↓, cell apoptosis ↓, NSC number ↑, new nerve cells ↑ | ||||||
Synapse protection | Ach ↑, BDNF ↑, multiple synaptic proteins ↑ | ||||||
Amelioration of AD-related pathology | APP ↓, Tau ↓, Aβ ↓ | ||||||
Compound | Ginsenoside Rg2 | Vascular dementia rat model | Anti-apoptosis | pro-apoptotic factors BAX and P53 ↓ | Zhang et al. (2008) | ||
anti-apoptotic BCL-2 and HSP70 ↑ | |||||||
Panax ginseng extract in concentrated form | Ginsenoside (G)-Rb1, G-Rb2, G-Rc, G-Rd, G-Re, G-Rf, G-Rg1, G-Rg2, G-Rg3 | Vascular dementia rat model | Anti-apoptosis | neuronal density ↑, VEGF and bFGF protein expression ↑, number of glial fibrillary acidic protein-immunoreactive cells ↓, BCl-2 ↑, BAX protein ↓ | Zhu et al. (2018) | ||
Neuroprotective effect | |||||||
Compound | Ginsenoside Rh1 | Sleep deprivation-induced mouse memory impairment model | Nootropic effects | Regulating oxidative stress levels in the cortex and hippocampus | Lu et al. (2017) | ||
Prevent sleep deprivation-induced memory impairment | |||||||
Compound | Ginsenoside Rh2 | Sleep deprivation-induced cognitive deficit mice | Reverse spatial and non-spatial memory impairments induced by sleep deprivation | Attenuating oxidative stress | Lu et al. (2018) | ||
Compound | Ginsenoside Rg1 | Rat model | Sleep-promoting (prolong sleep time and degrades sustainability of wakefulness) | Modulating the noradrenergic system in the locus coeruleus and serotonergic system in the dorsal raphe nucleus | Xu et al. (2019) | ||
Compound | Ginsenoside Rg5, Ginsenoside Rk1 | Rodent model | Sedative and hypnotic effects | Mediating the GABA/serotonin/glutamate nervous system | Shao et al. (2020) | ||
Shi chang pu | Acorus calamus var. angustatus Besser (synonyms: Acorus tatarinowii Schott, Acorus gramineus var. Crassispadix Lingelsh.) | Extract (water)/Extract (acetate)/Defatted decoction | α-asarone ß-asarone essential oil | Cognitive impairment mouse/rat models (cognitive impairment models were induced by lead, noise stress, LPS, Aβ1-42, D-gal plus AlCl3, scopolamine, ethanol, sodium nitrite, corticosterone, Ibotenic acid, chronic restraint stress, pentobarbital sodium, D-galactose, AlCl3, streptozotocin, pent ylenetet razol, NaNO2) | Anti-apoptosis | SOD ↑, CAT ↑, GSH-PX ↑, MDA ↓, HIF-1 ↓ | Li et al. (2020) |
Stimulating cholinergic system | AChE ↓, Ach ↑ | ||||||
Anti-apoptosis | BCL-2↑, BAX ↓, caspase 3 ↓, JNK ↓ | ||||||
Anti-inflammatory | TNF-α ↓, IL-1β ↓ | ||||||
Anti-neurotoxicity | APP ↓, Tau ↓ | ||||||
Anti-cytotoxicity | NOS ↓, NO ↓ | ||||||
Regulating synaptic plasticity | Dendritic spine density ↑, Synaptic loss ↓ | ||||||
Extract (ethanol: water (1:1)) | asarone | AD mice (scopolamine-induced AD) | Activating the cholinergic system | AChE ↓, GSH ↑, SOD ↑, Nitrite level ↓ | Malik et al. (2023) | ||
Antioxidant | |||||||
Neuroprotective effect | |||||||
Compound | β-asarone | In vitro (Aβ1-42 induced PC12 cell model of AD) | Protective effects against AD (the formation and damage of Aβ1-42) | Promote autophagy | Wang et al. (2019) | ||
Inhibit Aβ | |||||||
Compound | β-asarone | Aβ induced AD rat model | Antioxidant | SOD ↑, GPX ↑ | Saki et al. (2020) | ||
Neuroprotective effect | |||||||
Extract | volatile oil from Acorus gramineus | AD mice (Aβ1-42 injected mice) | Induce the regeneration of hippocampal neurons; promote the growth of hippocampal neurons and the clearance of Aβ | BDNF ↑, tyrosine protein kinase B ↑, neurotrophin-3 expression ↑ | Gao et al. (2019) | ||
Compound | α-asarone | Sleep deprivation rat model | Improve the quality of sleep | Minimum variation between hypothalamic temperature and body temperature, enhanced the association between NREM sleep about duration and hypothalamic temperature, thereby improving the quality of sleep | Radhakrishnan et al. (2017) | ||
Yuan zhi | Polygala tenuifolia Willd | Compound/Extract (water) | Polygala saponins | In vitro (Aβ-induced PC12 cells; BV2 cells) In vivo (D-galactose-induced aged mice, scopolamine-induced mice, chronic unpredictable mild stress-induced mice, APP/PS1 transgenic AD mice | Cognitive-improving effects | MAO ↓, AchE ↓, BDNF ↑, TrkB phosphorylation ↑, ASK1 ↓, JNK ↓, NT-3 ↑, NLRP3 inflammasome ↓, APP ↓, PS1/BACE1 interaction ↓ | (Zhang et al., 2023) |
Improvement of synaptic transmission | |||||||
Activation of MAPK cascades | |||||||
Anti-apoptosis | |||||||
Antioxidant | |||||||
Extract (ethanol) | Polygala tenuifolia root extract | Neural stem cells in the hippocampal CA1 region | Therapeutic effects for insomnia, neurosis, dementia | Promotes the proliferation of neural stem cells | Park et al. (2008) | ||
Promotes the neurite outgrowth of rat neuronal precursor cells, HiB5 | |||||||
Compound | Tenuifolin | Freely moving mice | Sleep-improving effects: prolong the total sleep time by increasing the amount of NREM and REM sleep | Activation of the GABAergic system | Cao et al. (2016) | ||
Inhibition the noradrenergic system |
Herb names in Pin yin were standardized based on the 2020 Pharmacopoeia of the People’s Republic of China (https://db.ouryao.com/yd2020/accessed 4 September 2023).
Plant names are sourced from the “World Flora Online” (www.worldfloraonline.org accessed 4 September 2023).
“↑” indicates an upward revision; “↓” indicates a downward revision. Abbreviations: Aβ, amyloid β; Ach, acetylcholine; AChE, acetylcholinesterase; AD, Alzheimer’s disease; APP, amyloid precursor protein; ASK1, Apoptosis signal-regulating kinase 1; BACE1, beta-site amyloid precursor protein cleaving enzyme 1; BCL-2: B-cell lymphoma/leukemia-2; BDNF, brain-derived neurotrophic factor; bFGF, basic fibroblast growth factor; CAT, catalase; GABA, γ-Aminobutyric acid; GPX, glutathione peroxidase; GSH-PX, GSH, peroxidase; HIF-1, hypoxia-inducible factor −1; IL, interleukin; JNK, c-Jun N-terminal kinase; MAO, monoamine oxidase; MAPK, mitogen-activated protein kinase; MDA, malondialdehyde; NLRP3, NOD-like receptor protein 3; NO, nitric oxide; NOS, nitric oxide synthase; NREM, sleep, non-rapid eye movement sleep; NSC, neural stem cell; NT-3, neurotrophin-3; REM, sleep, rapid eye movement sleep; ROS, reactive oxygen species; SOD, superoxide dismutase; TNF-α, tumor necrosis factor α; TrkB, tropomysin related kinase B; VEGF, vascular endothelial growth factor.